Annual Long Term Debt
$37.96 M
+$24.91 M+190.84%
December 31, 2021
Summary
- As of February 10, 2025, AVEO annual long term debt is $37.96 million, with the most recent change of +$24.91 million (+190.84%) on December 31, 2021.
- During the last 3 years, AVEO annual long term debt has risen by +$22.18 million (+140.57%).
Performance
AVEO Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Long Term Debt
$27.18 M
-$6.06 M-18.23%
September 30, 2022
Summary
- As of February 10, 2025, AVEO quarterly long term debt is $27.18 million, with the most recent change of -$6.06 million (-18.23%) on September 30, 2022.
- Over the past year, AVEO quarterly long term debt has dropped by -$5.86 million (-17.73%).
Performance
AVEO Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
AVEO Long Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +190.8% | -17.7% |
3 y3 years | +140.6% | +212.0% |
5 y5 years | +105.4% | +89.8% |
AVEO Long Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | at low | -28.8% | at low |
5 y | 5-year | at high | -83.7% | -28.8% | -94.8% |
alltime | all time | at high | -83.7% | -28.8% | -94.8% |
AVEO Pharmaceuticals Long Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2022 | - | $27.18 M(-18.2%) |
Jun 2022 | - | $33.25 M(-12.9%) |
Mar 2022 | - | $38.19 M(+0.6%) |
Dec 2021 | $37.96 M(+190.8%) | $37.96 M(+14.9%) |
Sep 2021 | - | $33.05 M(+0.5%) |
Jun 2021 | - | $32.87 M(+0.5%) |
Mar 2021 | - | $32.70 M(+150.5%) |
Dec 2020 | $13.05 M(+110.6%) | $13.05 M(-6.7%) |
Sep 2020 | - | $14.00 M(+890.5%) |
Jun 2020 | - | $1.41 M(-66.4%) |
Mar 2020 | - | $4.20 M(-32.2%) |
Dec 2019 | $6.20 M(-60.7%) | $6.20 M(-28.9%) |
Sep 2019 | - | $8.71 M(-22.0%) |
Jun 2019 | - | $11.17 M(-17.4%) |
Mar 2019 | - | $13.51 M(-14.4%) |
Dec 2018 | $15.78 M(-14.6%) | $15.78 M(+7.9%) |
Sep 2018 | - | $14.62 M(-10.5%) |
Jun 2018 | - | $16.34 M(-9.2%) |
Mar 2018 | - | $18.00 M(-2.6%) |
Dec 2017 | $18.48 M(+55.5%) | $18.48 M(+29.0%) |
Sep 2017 | - | $14.32 M(-10.8%) |
Jun 2017 | - | $16.07 M(+51.6%) |
Mar 2017 | - | $10.60 M(-10.8%) |
Dec 2016 | $11.88 M(+60.1%) | $11.88 M(-9.3%) |
Sep 2016 | - | $13.10 M(-4.6%) |
Jun 2016 | - | $13.73 M(+110.1%) |
Mar 2016 | - | $6.54 M(-11.9%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2015 | $7.42 M(-16.9%) | $7.42 M(-10.2%) |
Sep 2015 | - | $8.26 M(+12.9%) |
Jun 2015 | - | $7.32 M(-10.1%) |
Mar 2015 | - | $8.14 M(-8.9%) |
Dec 2014 | $8.93 M(+1.2%) | $8.93 M(-28.5%) |
Sep 2014 | - | $12.49 M(+304.5%) |
Jun 2014 | - | $3.09 M(-48.5%) |
Mar 2014 | - | $6.00 M(-32.0%) |
Dec 2013 | $8.82 M(-54.1%) | $8.82 M(-23.6%) |
Sep 2013 | - | $11.55 M(-18.6%) |
Jun 2013 | - | $14.18 M(-15.2%) |
Mar 2013 | - | $16.73 M(-13.0%) |
Dec 2012 | $19.23 M(+23.1%) | $19.23 M(-11.1%) |
Sep 2012 | - | $21.62 M(-9.6%) |
Jun 2012 | - | $23.93 M(-7.2%) |
Mar 2012 | - | $25.80 M(+65.2%) |
Dec 2011 | $15.62 M(-11.4%) | $15.62 M(-12.7%) |
Sep 2011 | - | $17.90 M(+0.5%) |
Jun 2011 | - | $17.82 M(-10.8%) |
Mar 2011 | - | $19.97 M(+13.2%) |
Dec 2010 | $17.64 M(+43.6%) | $17.64 M(-10.7%) |
Sep 2010 | - | $19.74 M(-9.2%) |
Jun 2010 | - | $21.75 M(+111.7%) |
Mar 2010 | - | $10.28 M(-16.3%) |
Dec 2009 | $12.28 M(-23.3%) | $12.28 M(-13.6%) |
Sep 2009 | - | $14.21 M(-11.3%) |
Dec 2008 | $16.02 M(+85.5%) | $16.02 M |
Dec 2007 | $8.63 M | - |
FAQ
- What is AVEO Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for AVEO Pharmaceuticals?
- What is AVEO Pharmaceuticals annual long term debt year-on-year change?
- What is AVEO Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for AVEO Pharmaceuticals?
- What is AVEO Pharmaceuticals quarterly long term debt year-on-year change?
What is AVEO Pharmaceuticals annual long term debt?
The current annual long term debt of AVEO is $37.96 M
What is the all time high annual long term debt for AVEO Pharmaceuticals?
AVEO Pharmaceuticals all-time high annual long term debt is $37.96 M
What is AVEO Pharmaceuticals annual long term debt year-on-year change?
Over the past year, AVEO annual long term debt has changed by +$24.91 M (+190.84%)
What is AVEO Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of AVEO is $27.18 M
What is the all time high quarterly long term debt for AVEO Pharmaceuticals?
AVEO Pharmaceuticals all-time high quarterly long term debt is $38.19 M
What is AVEO Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, AVEO quarterly long term debt has changed by -$5.86 M (-17.73%)